Recruiting NA INTERVENTIONAL 2-arm NCT06065436

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Impact of Concurrent Low Intensity Shockwave Therapy on Clinical Outcomes With Collagenase Clostridium Histolyticum in Peyronie's Disease: A Randomized Controlled Trial

Sponsor: Mayo Clinic

Conditions Erectile Dysfunction Peyronie Disease

Interventions Collagenase Clostridium Histolyticum Storz Duolith LiSWT

Updated 6 times since 2023 Last updated: Jan 5, 2026 Started: Jan 19, 2024 Primary completion: Dec 31, 2026 Completion: Jan 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Erectile Dysfunction and Peyronie Disease and is currently actively recruiting participants. Mayo Clinic leads this study, which shows 6 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA
May 2025 — Feb 2026 [monthly]

Recruiting NA
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2024 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Nov 2023 — May 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States